A detailed history of Unio Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Unio Capital LLC holds 827 shares of AMGN stock, worth $218,733. This represents 0.11% of its overall portfolio holdings.

Number of Shares
827
Previous 827 -0.0%
Holding current value
$218,733
Previous $258,000 3.1%
% of portfolio
0.11%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $2,627 - $3,193
-10 Reduced 1.19%
827 $258,000
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $13,443 - $16,228
-50 Reduced 5.64%
837 $237,000
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $193,942 - $240,785
887 New
887 $238,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $22,579 - $27,520
-100 Reduced 10.13%
887 $214,000
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $21,927 - $24,257
-100 Reduced 9.2%
987 $239,000
Q3 2020

Nov 16, 2020

SELL
$234.65 - $260.95 $23,465 - $26,095
-100 Reduced 8.42%
1,087 $251,000
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $41,342 - $50,732
-209 Reduced 14.97%
1,187 $280,000
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $13,668 - $18,127
-75 Reduced 5.1%
1,396 $283,000
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $37,842 - $48,640
-200 Reduced 11.97%
1,471 $355,000
Q2 2019

Aug 14, 2019

SELL
$166.7 - $195.41 $177,202 - $207,720
-1,063 Reduced 38.88%
1,671 $311,000
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $13,565 - $15,291
-75 Reduced 2.67%
2,734 $519,000
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $22,300 - $26,031
125 Added 4.66%
2,809 $547,000
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $23,161 - $26,111
-125 Reduced 4.45%
2,684 $556,000
Q2 2018

Aug 13, 2018

BUY
$166.05 - $186.51 $33,210 - $37,302
200 Added 7.67%
2,809 $519,000
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $156,722 - $183,150
-925 Reduced 26.17%
2,609 $445,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $596,503 - $666,477
3,534
3,534 $615,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Unio Capital LLC Portfolio

Follow Unio Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Unio Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Unio Capital LLC with notifications on news.